Stramsen Biotech Inc. Announced $25 Million Funding Commitment from GEM Global Yield LLC SCS (“GEM”)
Financing commitment positions Stramsen for growth and accelerated clinical development. HOUSTON, April 7, 2025 /PRNewswire/ — Stramsen Biotech Inc, an emerging leader in plant-based biopharmaceutical industry, today announced that it has signed a binding agreement with GEM Global…